Respiratory syncytial virus infection triggers epithelial HMGB1 release as a damage-associated molecular pattern promoting a monocytic inflammatory response

Journal of Virology

Volumn 90, Issue 21, 2016, Pages 9618-9631

  Hosakote, Yashoda M ^a,b   Brasier, Allan R ^a,b   Casola, Antonella ^a,b   Garofalo, Roberto P ^a,b   Kurosky, Alexander ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; HIGH MOBILITY GROUP B1 PROTEIN; RECOMBINANT PROTEIN; HMGB1 PROTEIN, HUMAN;

A549 CELL LINE; AIRWAY EPITHELIAL CELL; ARTICLE; CELL ACTIVATION; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; EXTRACELLULAR SPACE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOREGULATION; INFLAMMATION; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEIN TRANSPORT; RESPIRATORY SYNCYTIAL VIRUS INFECTION; WESTERN BLOTTING; A-549 CELL LINE; ADOLESCENT; ADULT; EPITHELIUM CELL; HUMAN RESPIRATORY SYNCYTIAL VIRUS; LUNG; METABOLISM; MIDDLE AGED; MONOCYTE; PNEUMONIA; TUMOR CELL LINE; VIROLOGY; YOUNG ADULT;

A549 CELLS; ADOLESCENT; ADULT; CELL LINE, TUMOR; EPITHELIAL CELLS; HMGB1 PROTEIN; HUMANS; LUNG; MIDDLE AGED; MONOCYTES; PNEUMONIA; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; YOUNG ADULT;

EID: 84993960942     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01279-16     Document Type: Article

References (74)

1. Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE. 2005. Respiratory syncytial virus infection in elderly and high-risk adults.NEngl J Med 352:1749-1759. http://dx.doi.org/10.1056/NEJMoa043951.
2. Hall CB, Weinberg GA, Iwane MK, Blumkin AK, Edwards KM, Staat MA, Auinger P, Griffin MR, Poehling KA, Erdman D, Grijalva CG, Zhu Y, Szilagyi P. 2009. The burden of respiratory syncytial virus infection in young children. N Engl J Med 360:588-598. http://dx.doi.org/10.1056/NEJMoa0804877.
3. Brasier AR, Tian B, Jamaluddin M, Kalita MK, Garofalo RP, Lu M. 2011. RelA Ser276 phosphorylation-coupled Lys310 acetylation controls transcriptional elongation of inflammatory cytokines in respiratory syncytial virus infection. J Virol 85:11752-11769. http://dx.doi.org/10.1128/JVI.05360-11.
4. Tian B, Zhang Y, Luxon BA, Garofalo RP, Casola A, Sinha M, Brasier AR. 2002. Identification of NF-kappaB-dependent gene networks in respiratory syncytial virus-infected cells. J Virol 76:6800-6814. http://dx.doi.org/10.1128/JVI.76.13.6800-6814.2002.
5. Tian B, Zhao Y, Kalita M, Edeh CB, Paessler S, Casola A, Teng MN, Garofalo RP, Brasier AR. 2013. CDK9-dependent transcriptional elongation in the innate interferon-stimulated gene response to respiratory syncytial virus infection in airway epithelial cells. J Virol 87:7075-7092. http://dx.doi.org/10.1128/JVI.03399-12.
6. Macnee W. 2001. Oxidative stress and lung inflammation in airways disease. Eur J Pharmacol 429:195-207. http://dx.doi.org/10.1016/S0014-2999(01)01320-6.
7. Rahman I, Morrison D, Donaldson K, Macnee W. 1996. Systemic oxidative stress in asthma, COPD, and smokers. Am J Respir Crit Care Med 154:1055-1060. http://dx.doi.org/10.1164/ajrccm.154.4.8887607.
8. Castro SM, Guerrero-Plata A, Suarez-Real G, Adegboyega PA, Colasurdo GN, Khan AM, Garofalo RP, Casola A. 2006. Antioxidant treatment ameliorates respiratory syncytial virus-induced disease and lung inflammation. AmJ Respir Crit Care Med 174:1361-1369. http://dx.doi.org/10.1164/rccm.200603-319OC.
9. Liu T, Castro S, Brasier AR, Jamaluddin M, Garofalo RP, Casola A. 2004. Reactive oxygen species mediate virus-induced STAT activation: role of tyrosine phosphatases. J Biol Chem 279:2461-2469. http://dx.doi.org/10.1074/jbc.M307251200.
10. Hou CC, Zhao HJ, Cai SX, Li WJ, Tong WC, Liu LY. 2010. Respiratory syncytial virus increases the expression and release of high mobility group Box-1 protein in the lung tissue of mice. Nan Fang Yi Ke Da Xue Xue Bao 30:700-703.
11. Stros M. 2010. HMGB proteins: interactions with DNA and chromatin. Biochim Biophys Acta 1799:101-113. http://dx.doi.org/10.1016/j.bbagrm.2009.09.008.
12. Ulloa L, Batliwalla FM, Andersson U, Gregersen PK, Tracey KJ. 2003. High mobility group box chromosomal protein 1 as a nuclear protein, cytokine, and potential therapeutic target in arthritis. Arthritis Rheum 48:876-881. http://dx.doi.org/10.1002/art.10854.
13. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, Frazier A, Yang H, Ivanova S, Borovikova L, Manogue KR, Faist E, Abraham E, Andersson J, Andersson U, Molina PE, Abumrad NN, Sama A, Tracey KJ. 1999. HMG-1 as a late mediator of endotoxin lethality in mice. Science 285:248-251. http://dx.doi.org/10.1126/science.285.5425.248.
14. Sims GP, Rowe DC, Rietdijk ST, Herbst R, Coyle AJ. 2010. HMGB1 and RAGE in inflammation and cancer. Annu Rev Immunol 28:367-388. http://dx.doi.org/10.1146/annurev.immunol.021908.132603.
15. Oozawa S, Mori S, Kanke T, Takahashi H, Liu K, Tomono Y, Asanuma M, Miyazaki I, Nishibori M, Sano S. 2008. Effects of HMGB1 on ischemia-reperfusion injury in the rat heart. Circ J 72:1178-1184. http://dx.doi.org/10.1253/circj.72.1178.
16. Ferhani N, Letuve S, Kozhich A, Thibaudeau O, Grandsaigne M, Maret M, Dombret MC, Sims GP, Kolbeck R, Coyle AJ, Aubier M, Pretolani M. 2010. Expression of high-mobility group box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 181:917-927. http://dx.doi.org/10.1164/rccm.200903-0340OC.
17. Hamada N, Maeyama T, Kawaguchi T, Yoshimi M, Fukumoto J, Yamada M, Yamada S, Kuwano K, Nakanishi Y. 2008. The role of high mobility group box1 in pulmonary fibrosis. Am J Respir Cell Mol Biol 39:440-447. http://dx.doi.org/10.1165/rcmb.2007-0330OC.
18. Lee CC, Lai YT, Chang HT, Liao JW, Shyu WC, Li CY, Wang CN. 2013. Inhibition of high-mobility group box 1 in lung reduced airway inflammation and remodeling in a mouse model of chronic asthma. Biochem Pharmacol 86:940-949. http://dx.doi.org/10.1016/j.bcp.2013.08.003.
19. Ma L, Zeng J, Mo B, Wang C, Huang J, Sun Y, Yu Y, Liu S. 2015. High mobility group box 1: a novel mediator of Th2-type response-induced airway inflammation of acute allergic asthma. J Thorac Dis 7:1732-1741.
20. Zhang F, Huang G, Hu B, Fang LP, Cao EH, Xin XF, Song Y, Shi Y. 2014. Anti-HMGB1 neutralizing antibody ameliorates neutrophilic airway inflammation by suppressing dendritic cell-mediated Th17 polarization. Mediators Inflamm 2014:257930.
21. Scaffidi P, Misteli T, Bianchi ME. 2002. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418:191-195. http://dx.doi.org/10.1038/nature00858.
22. Jung JH, Park JH, Jee MH, Keum SJ, Cho MS, Yoon SK, Jang SK. 2011. Hepatitis C virus infection is blocked by HMGB1 released from virus-infected cells. J Virol 85:9359-9368. http://dx.doi.org/10.1128/JVI.00682-11.
23. Rendon-Mitchell B, Ochani M, Li J, Han J, Wang H, Yang H, Susarla S, Czura C, Mitchell RA, Chen G, Sama AE, Tracey KJ, Wang H. 2003. IFN-gamma induces high mobility group box 1 protein release partly through a TNF-dependent mechanism. J Immunol 170:3890-3897. http://dx.doi.org/10.4049/jimmunol.170.7.3890.
24. Taniguchi N, Kawahara K, Yone K, Hashiguchi T, Yamakuchi M, Goto M, Inoue K, Yamada S, Ijiri K, Matsunaga S, Nakajima T, Komiya S, Maruyama I. 2003. High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine. Arthritis Rheum 48:971-981. http://dx.doi.org/10.1002/art.10859.
25. Tsung A, Sahai R, Tanaka H, Nakao A, Fink MP, Lotze MT, Yang H, Li J, Tracey KJ, Geller DA, Billiar TR. 2005. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med 201:1135-1143. http://dx.doi.org/10.1084/jem.20042614.
26. Wang H, Liao H, Ochani M, Justiniani M, Lin X, Yang L, Al-Abed Y, Wang H, Metz C, Miller EJ, Tracey KJ, Ulloa L. 2004. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat Med 10:1216-1221. http://dx.doi.org/10.1038/nm1124.
27. Bonaldi T, Talamo F, Scaffidi P, Ferrera D, Porto A, Bachi A, Rubartelli A, Agresti A, Bianchi ME. 2003. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J 22:5551-5560. http://dx.doi.org/10.1093/emboj/cdg516.
28. Lotze MT, Tracey KJ. 2005. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol 5:331-342. http://dx.doi.org/10.1038/nri1594.
29. Tang D, Shi Y, Jang L, Wang K, Xiao W, Xiao X. 2005. Heat shock response inhibits release of high mobility group box 1 protein induced by endotoxin in murine macrophages. Shock 23:434-440. http://dx.doi.org/10.1097/01.shk.0000159556.95285.df.
30. Vande WL, Kanneganti TD, Lamkanfi M. 2011. HMGB1 release by inflammasomes. Virulence 2:162-165. http://dx.doi.org/10.4161/viru.2.2.15480.
31. Park JS, Svetkauskaite D, He Q, Kim JY, Strassheim D, Ishizaka A, Abraham E. 2004. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem 279:7370-7377. http://dx.doi.org/10.1074/jbc.M306793200.
32. Andersson U, Wang H, Palmblad K, Aveberger AC, Bloom O, Erlandsson-Harris H, Janson A, Kokkola R, Zhang M, Yang H, Tracey KJ. 2000. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med 192:565-570. http://dx.doi.org/10.1084/jem.192.4.565.
33. Tang D, Kang R, Cheh CW, Livesey KM, Liang X, Schapiro NE, Benschop R, Sparvero LJ, Amoscato AA, Tracey KJ, Zeh HJ, Lotze MT. 2010. HMGB1 release and redox regulates autophagy and apoptosis in cancer cells. Oncogene 29:5299-5310. http://dx.doi.org/10.1038/onc.2010.261.
34. Olszewska-Pazdrak B, Casola A, Saito T, Alam R, Crowe SE, Mei F, Ogra PL, Garofalo RP. 1998. Cell-specific expression of RANTES, MCP-1, and MIP-1alpha by lower airway epithelial cells and eosinophils infected with respiratory syncytial virus. J Virol 72:4756-4764.
35. Ueba O. 1978. Respiratory syncytial virus. I. Concentration and purification of the infectious virus. Acta Med Okayama 32:265-272.
36. Kisch AL, Johnson KM. 1963. A plaque assay for respiratory syncytial virus. Proc Soc Exp Biol Med 112:583-589. http://dx.doi.org/10.3181/00379727-112-28111.
37. Garofalo R, Sabry M, Jamaluddin M, Yu RK, Casola A, Ogra PL, Brasier AR. 1996. Transcriptional activation of the interleukin-8 gene by respiratory syncytial virus infection in alveolar epithelial cells: nuclear translocation of the RelA transcription factor as a mechanism producing airway mucosal inflammation. J Virol 70:8773-8781.
38. Casola A, Burger N, Liu T, Jamaluddin M, Brasier AR, Garofalo RP. 2001. Oxidant tone regulates RANTES gene expression in airway epithelial cells infected with respiratory syncytial virus. Role in viral-induced interferon regulatory factor activation. J Biol Chem 276:19715-19722.
39. Pazdrak K, Olszewska-Pazdrak B, Liu T, Takizawa R, Brasier AR, Garofalo RP, Casola A. 2002. MAPK activation is involved in posttranscriptional regulation of RSV-induced RANTES gene expression. Am J Physiol Lung Cell Mol Physiol 283:L364-L372. http://dx.doi.org/10.1152/ajplung.00331.2001.
40. Tang D, Kang R, Livesey KM, Cheh CW, Farkas A, Loughran P, Hoppe G, Bianchi ME, Tracey KJ, Zeh HJ, III, Lotze MT. 2010. Endogenous HMGB1 regulates autophagy. J Cell Biol 190:881-892. http://dx.doi.org/10.1083/jcb.200911078.
41. Garofalo RP, Goldman AS. 1999. Expression of functional immunomodulatory and anti-inflammatory factors in human milk. Clin Perinatol 26:361-377.
42. Graham BS, Johnson TR, Peebles RS. 2000. Immune-mediated disease pathogenesis in respiratory syncytial virus infection. Immunopharmacology 48:237-247. http://dx.doi.org/10.1016/S0162-3109(00)00233-2.
43. Zhang Y, Luxon BA, Casola A, Garofalo RP, Jamaluddin M, Brasier AR. 2001. Expression of respiratory syncytial virus-induced chemokine gene networks in lower airway epithelial cells revealed by cDNA microarrays. J Virol 75:9044-9058. http://dx.doi.org/10.1128/JVI.75.19.9044-9058.2001.
44. Hosakote YM, Komaravelli N, Mautemps N, Liu T, Garofalo RP, Casola A. 2012. Antioxidant mimetics modulate oxidative stress and cellular signaling in airway epithelial cells infected with respiratory syncytial virus. Am J Physiol Lung Cell Mol Physiol 303:L991-L1000. http://dx.doi.org/10.1152/ajplung.00192.2012.
45. Hosakote YM, Liu T, Castro SM, Garofalo RP, Casola A. 2009. Respiratory syncytial virus induces oxidative stress by modulating antioxidant enzymes. Am J Respir Cell Mol Biol 41:348-357. http://dx.doi.org/10.1165/rcmb.2008-0330OC.
46. Hoppe G, Talcott KE, Bhattacharya SK, Crabb JW, Sears JE. 2006. Molecular basis for the redox control of nuclear transport of the structural chromatin protein Hmgb1. Exp Cell Res 312:3526-3538. http://dx.doi.org/10.1016/j.yexcr.2006.07.020.
47. Tang D, Kang R, Zeh HJ, III, Lotze MT. 2011. High-mobility group box 1, oxidative stress, and disease. Antioxid Redox Signal 14:1315-1335. http://dx.doi.org/10.1089/ars.2010.3356.
48. Tang D, Shi Y, Kang R, Li T, Xiao W, Wang H, Xiao X. 2007. Hydrogen peroxide stimulates macrophages and monocytes to actively release HMGB1. J Leukoc Biol. 81:741-747.
49. Barqasho B, Nowak P, Abdurahman S, Walther-Jallow L, Sonnerborg A. 2010. Implications of the release of high-mobility group box 1 protein from dying cells during human immunodeficiency virus type 1 infection in vitro. J Gen Virol 91:1800-1809. http://dx.doi.org/10.1099/vir.0.016915-0.
50. Hou XQ, Qin JL, Zheng XX, Wang L, Yang ST, Gao YW, Xia XZ. 2014. Potential role of high-mobility group box 1 protein in the pathogenesis of influenza H5N1 virus infection. Acta Virol 58:69-75. http://dx.doi.org/10.4149/av_2014_01_69.
51. Ong SP, Lee LM, Leong YF, Ng ML, Chu JJ. 2012. Dengue virus infection mediatesHMGB1release from monocytes involving PCAF acetylase complex and induces vascular leakage in endothelial cells. PLoS One 7:e41932. http://dx.doi.org/10.1371/journal.pone.0041932.
52. Borde C, Barnay-Verdier S, Gaillard C, Hocini H, Marechal V, Gozlan J. 2011. Stepwise release of biologically active HMGB1 during HSV-2 infection. PLoS One 6:e16145. http://dx.doi.org/10.1371/journal.pone.0016145.
53. Wang H, Ward MF, Fan XG, Sama AE, Li W. 2006. Potential role of high mobility group box 1 in viral infectious diseases. Viral Immunol 19:3-9. http://dx.doi.org/10.1089/vim.2006.19.3.
54. Cuppari C, Manti S, Chirico V, Caruso R, Salpietro V, Giacchi V, Lagana F, Arrigo T, Salpietro C, Leonardi S. 2015. Sputum high mobility group box-1 in asthmatic children: a noninvasive sensitive biomarker reflecting disease status. Ann Allergy Asthma Immunol 115:103-107. http://dx.doi.org/10.1016/j.anai.2015.06.008.
55. Hou C, Kong J, Liang Y, Huang H, Wen H, Zheng X, Wu L, Chen Y. 2015. HMGB1 contributes to allergen-induced airway remodeling in a murine model of chronic asthma by modulating airway inflammation and activating lung fibroblasts. Cell Mol Immunol 12:409-423. http://dx.doi.org/10.1038/cmi.2014.60.
56. Hou C, Zhao H, Liu L, Li W, Zhou X, Lv Y, Shen X, Liang Z, Cai S, Zou F. 2011. High mobility group protein B1 (HMGB1) in asthma: comparison of patients with chronic obstructive pulmonary disease and healthy controls. Mol Med 17:807-815.
57. Kanazawa H, Tochino Y, Asai K, Ichimaru Y, Watanabe T, Hirata K. 2012. Validity of HMGB1 measurement in epithelial lining fluid in patients with COPD. Eur J Clin Investig 42:419-426. http://dx.doi.org/10.1111/j.1365-2362.2011.02598.x.
58. Watanabe T, Asai K, Fujimoto H, Tanaka H, Kanazawa H, Hirata K. 2011. Increased levels of HMGB-1 and endogenous secretory RAGE in induced sputum from asthmatic patients. Respir Med 105:519-525. http://dx.doi.org/10.1016/j.rmed.2010.10.016.
59. Hosakote YM, Jantzi PD, Esham DL, Spratt H, Kurosky A, Casola A, Garofalo RP. 2011. Viral-mediated inhibition of antioxidant enzymes contributes to the pathogenesis of severe respiratory syncytial virus bronchiolitis. Am J Respir Crit Care Med 183:1550-1560. http://dx.doi.org/10.1164/rccm.201010-1755OC.
60. Yao D, Brownlee M. 2010. Hyperglycemia-induced reactive oxygen species increase expression of the receptor for advanced glycation end products (RAGE) and RAGE ligands. Diabetes 59:249-255. http://dx.doi.org/10.2337/db09-0801.
61. Bamboat ZM, Balachandran VP, Ocuin LM, Obaid H, Plitas G, De-Matteo RP. 2010. Toll-like receptor 9 inhibition confers protection from liver ischemia-reperfusion injury. Hepatology 51:621-632. http://dx.doi.org/10.1002/hep.23365.
62. Kruger B, Krick S, Dhillon N, Lerner SM, Ames S, Bromberg JS, Lin M, Walsh L, Vella J, Fischereder M, Kramer BK, Colvin RB, Heeger PS, Murphy BT, Schroppel B. 2009. Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation. Proc Natl Acad Sci U S A 106:3390-3395. http://dx.doi.org/10.1073/pnas.0810169106.
63. Zeng S, Dun H, Ippagunta N, Rosario R, Zhang QY, Lefkowitch J, Yan SF, Schmidt AM, Emond JC. 2009. Receptor for advanced glycation end product (RAGE)-dependent modulation of early growth response-1 in hepatic ischemia/reperfusion injury. J Hepatol 50:929-936. http://dx.doi.org/10.1016/j.jhep.2008.11.022.
64. Kregel KC, Zhang HJ. 2007. An integrated view of oxidative stress in aging: basic mechanisms, functional effects, and pathological considerations. Am J Physiol Regul Integr Comp Physiol 292:R18-R36.
65. Li J, Kokkola R, Tabibzadeh S, Yang R, Ochani M, Qiang X, Harris HE, Czura CJ, Wang H, Ulloa L, Wang H, Warren HS, Moldawer LL, Fink MP, Andersson U, Tracey KJ, Yang H. 2003. Structural basis for the proinflammatory cytokine activity of high mobility group box 1. Mol Med 9:37-45.
66. Bianchi ME. 2009. HMGB1 loves company. J Leukoc Biol 86:573-576. http://dx.doi.org/10.1189/jlb.1008585.
67. Kinnula VL, Crapo JD. 2003. Superoxide dismutases in the lung and human lung diseases. Am J Respir Crit Care Med 167:1600-1619. http://dx.doi.org/10.1164/rccm.200212-1479SO.
68. El-Saghire H, Michaux A, Thierens H, Baatout S. 2013. Low doses of ionizing radiation induce immune-stimulatory responses in isolated human primary monocytes. Int J Mol Med 32:1407-1414.
69. Gremion C, Cerny A. 2005. Hepatitis C virus and the immune system: a concise review. Rev Med Virol 15:235-268. http://dx.doi.org/10.1002/rmv.466.
70. Lee FE, Walsh EE, Falsey AR, Lumb ME, Okam NV, Liu N, Divekar AA, Hall CB, Mosmann TR. 2007. Human infant respiratory syncytial virus (RSV)-specific type 1 and 2 cytokine responses ex vivo during primary RSV infection. J Infect Dis 195:1779-1788. http://dx.doi.org/10.1086/518249.
71. Morris S, Swanson MS, Lieberman A, Reed M, Yue Z, Lindell DM, Lukacs NW. 2011. Autophagy-mediated dendritic cell activation is essential for innate cytokine production and APC function with respiratory syncytial virus responses. J Immunol 187:3953-3961. http://dx.doi.org/10.4049/jimmunol.1100524.
72. Reed M, Morris SH, Jang S, Mukherjee S, Yue Z, Lukacs NW. 2013. Autophagy-inducing protein beclin-1 in dendritic cells regulates CD4 T cell responses and disease severity during respiratory syncytial virus infection. J Immunol 191:2526-2537. http://dx.doi.org/10.4049/jimmunol.1300477.
73. Srinivasakumar N, Ogra PL, Flanagan TD. 1991. Characteristics of fusion of respiratory syncytial virus with HEp-2 cells as measured by R18 fluorescence dequenching assay. J Virol 65:4063-4069.
74. Yang L, Chai W, Wang Y, Cao L, Xie M, Yang M, Kang R, Yu Y. 2015. Reactive oxygen species regulate the differentiation of acute promyelocytic leukemia cells through HMGB1-mediated autophagy. Am J Cancer Res 5:714-725.